H.R. 5687 directs the Food and Drug Administration (FDA) to work with manufacturers to establish programs for efficient return or destruction of unused Schedule II or III opioids. These methods could include mail-back pouches to secure facilities for incineration, or methods to inactivate immediately or render unattractive unused drugs. In addition, this bill will facilitate utilization of packaging that may reduce overprescribing, diversion, or abuse of opioids. Finally, the bill will require the Government Accountability Office (GAO) to study new and innovative technologies that claim to be able to dispose of opioids safely and other unused medications. GAO would review and detail the effectiveness of these disposal methods.
The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress, and was published on May 7, 2018.
Securing Opioids and Unused Narcotics with Deliberate Disposal and Packaging Act of 2018 or the SOUND Disposal and Packaging Act
This bill amends the Federal Food, Drug, and Cosmetic Act to authorize the Food and Drug Administration to require certain packaging and disposal technologies, controls, or measures to mitigate the risk of abuse or misuse of a drug or a class of drugs.